Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review

6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Curcumin has anti-inflammatory, antioxidant, and anticancer effects and is used to treat diseases such as dermatological diseases, infection, stress, depression, and anxiety. J147, an analogue of curcumin, is designed and synthesized with better stability and bioavailability. Accumulating evidence demonstrates the potential role of J147 in the prevention and treatment of Alzheimer’s disease, diabetic neuropathy, ischemic stroke, depression, anxiety, and fatty liver disease. In this narrative review, we summarized the background and biochemical properties of J147 and discussed the role and mechanism of J147 in different diseases. Overall, the mechanical attributes of J147 connote it as a potential target for the prevention and treatment of neurological diseases.

Cite

CITATION STYLE

APA

Qiu, F., Wang, Y., Du, Y., Zeng, C., Liu, Y., Pan, H., & Ke, C. (2023, December 1). Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review. BMC Neurology. BioMed Central Ltd. https://doi.org/10.1186/s12883-023-03358-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free